| Authors: |
Li C; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Madan RA; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Lee MJ; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, Maryland, USA., Lee S; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, Maryland, USA., Sato N; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, Maryland, USA., Rastogi S; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, Maryland, USA., Shrestha R; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, Maryland, USA., Aragon-Ching JB; Inova Schar Cancer Institute, Fairfax, Virginia, USA., Goswami M; Center for Immuno-Oncology, National Cancer Institute, Bethesda, Maryland, USA., Donahue RN; Center for Immuno-Oncology, National Cancer Institute, Bethesda, Maryland, USA., Cordes LM; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Baj A; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Seo CCY; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Terrigino NT; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Bright JR; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Hennigan ST; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., King IM; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Trostel SY; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Fenimore JM; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Liu Y; Genetics Branch, National Cancer Institute, Bethesda, Maryland, USA., Calzone KA; Genetics Branch, National Cancer Institute, Bethesda, Maryland, USA., Schlom J; Center for Immuno-Oncology, National Cancer Institute, Bethesda, Maryland, USA., Gulley JL; Center for Immuno-Oncology, National Cancer Institute, Bethesda, Maryland, USA., Dahut WL; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Figg WD; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Sowalsky AG; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Lee JM; Women's Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Karzai F; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA fatima.karzai@nih.gov. |
